Equities Research Analysts’ updated eps estimates for Wednesday, September 21st:

Accenture PLC (NYSE:ACN) had its hold rating reissued by analysts at Morgan Stanley. Morgan Stanley currently has a $120.00 price target on the stock.

AGF Management Limited (TSE:AGF.B) had its underperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a C$5.00 price target on the stock.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/equities-research-analysts-updated-eps-estimates-for-september-21st-acn-agf-b-agn-amx-avgo-bayn-clvs-cpg-dgi-eqm.html

Allergan PLC (NYSE:AGN) was downgraded by analysts at Cantor Fitzgerald from a buy rating to a hold rating.

Amer Movil (NYSE:AMX) had its hold rating reissued by analysts at Credit Suisse Group AG. Credit Suisse Group AG currently has a $12.00 target price on the stock.

Broadcom (NASDAQ:AVGO) had its buy rating reissued by analysts at Brean Capital.

Bayer AG (FRA:BAYN) was given a €105.00 ($116.67) price target by analysts at Societe Generale. The firm currently has a a neutral rating on the stock.

Clovis Oncology (NASDAQ:CLVS) was downgraded by analysts at Janney Montgomery Scott from a buy rating to a neutral rating.

Crescent Point Energy Corp (TSE:CPG) had its price target lowered by CIBC from C$26.00 to C$22.00.

DigitalGlobe (NYSE:DGI) had its hold rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $20.00 target price on the stock.

EQT Midstream Partners (NYSE:EQM) had its hold rating reiterated by analysts at Morgan Stanley. The firm currently has a $83.00 target price on the stock.

FedEx (NYSE:FDX) was given a $159.00 price target by analysts at Sanford C. Bernstein. The firm currently has a a neutral rating on the stock.

The Finish Line (NASDAQ:FINL) had its buy rating reissued by analysts at Canaccord Genuity. Canaccord Genuity currently has a $25.00 target price on the stock.

The Finish Line (NASDAQ:FINL) had its hold rating reissued by analysts at Piper Jaffray Cos..

Lennar Corp. (NYSE:LEN) had its outperform rating reiterated by analysts at FBR & Co.

Mirna Therapeutics (NASDAQ:MIRN) had its neutral rating reiterated by analysts at Leerink Swann. The analysts wrote, “We maintain our Market Perform rating for Amgen along with our $193 price target.””

Mallinckrodt PLC (NYSE:MNK) had its buy rating reaffirmed by analysts at Morgan Stanley. Morgan Stanley currently has a $82.00 price target on the stock.

Nike (NYSE:NKE) had its hold rating reaffirmed by analysts at Morgan Stanley. The firm currently has a $60.00 price target on the stock.

PetroChina (NYSE:PTR) was upgraded by analysts at Macquarie from a neutral rating to an outperform rating.

Qorvo (NASDAQ:QRVO) had its buy rating reissued by analysts at Brean Capital.

Regeneron Pharmaceuticals (NASDAQ:REGN) had its buy rating reissued by analysts at Leerink Swann. The firm currently has a $530.00 target price on the stock.

Skyworks Solutions (NASDAQ:SWKS) had its buy rating reaffirmed by analysts at Brean Capital.

Tessera Technologies (NASDAQ:TSRA) had its buy rating reissued by analysts at Benchmark Co.. The firm currently has a $45.00 price target on the stock. The analysts wrote, “We believe DTS is an indication of management dedication to do so.””

United Microelectronics Corp (NYSE:UMC) was downgraded by analysts at Daiwa Capital Markets from a buy rating to a hold rating.

WebMD Health Corp. (NASDAQ:WBMD) had its buy rating reissued by analysts at Leerink Swann. The analysts wrote, “We are somewhat surprised by the CEO change, given the company’s strong performance particularly over the last year. However from our conversation with the company we believe Dr. Zatz has been running many of the day-to-day operations of the business and he is viewed as a strong internal leader both by customers and employees of the business. Given Dr.””

Tmx Group Limited (TSE:X) had its target price increased by CIBC from C$63.00 to C$66.00.

Zogenix (NASDAQ:ZGNX) had its buy rating reiterated by analysts at Brean Capital. They currently have a $28.00 price target on the stock.

Receive News & Ratings for Accenture PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture PLC and related companies with MarketBeat.com's FREE daily email newsletter.